Uae Ai In Oncology Market Size & Outlook, 2026-2033
The ai in oncology market in the UAE is expected to reach a projected revenue of US$ 310.6 million by 2033. A compound annual growth rate of 26% is expected of the UAE ai in oncology market from 2026 to 2033.
The UAE ai in oncology market generated a revenue of USD 44.4 million in 2025 and is expected to reach USD 310.6 million by 2033.
The UAE market is expected to grow at a CAGR of 26% from 2026 to 2033.
In terms of segment, hardware was the largest revenue generating component in 2025.
Software Solutions is the most lucrative component segment registering the fastest growth during the forecast period.
Ai in oncology market data book summary
Market revenue in 2025
USD 44.4 million
Market revenue in 2033
USD 310.6 million
Growth rate
26% (CAGR from 2026 to 2033)
Largest segment
Hardware
Fastest growing segment
Software Solutions
Historical data
2021 - 2024
Base year
2025
Forecast period
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Hardware, Software Solutions, Services
Key market players worldwide
International Business Machines Corp, Siemens Healthineers AG ADR, Intel Corp, GE HealthCare Technologies Inc Common Stock, NVIDIA Corp
Other key industry trends
In terms of revenue, UAE accounted for 0.7% of the global ai in oncology market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Middle East & Africa, South Africa ai in oncology market is projected to lead the regional market in terms of revenue in 2033.
UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 310.6 million by 2033.
Research institutes play a crucial role in driving the UAE AI in oncology market by contributing to advancements in AI technology and its application in the field of oncology. Through extensive R&D activities, these institutes work on refining AI algorithms, analyzing large datasets, and developing innovative solutions that can enhance cancer therapy.
Furthermore, hospitals are adopting AI technologies for cancer detection, diagnosis, treatment planning, and patient management. By incorporating AI algorithms, cancer hospitals can analyze medical images, genomic data, and other patient information more efficiently and accurately.
For instance, in August 2023, MBZUAI generated an AI model for accurate few-shot tissue image generation to recognize various cancer tissues. In May 2023, Cleveland Clinic Abu Dhabi introduced the Fatima bint Mubarak Center. The center uses Ethos adaptive radiotherapy, an AI-ML-based cancer treatment technology.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to AI In Oncology Market Outlook will help companies and investors design strategic landscapes.
Hardware was the largest segment with a revenue share of 54.95% in 2025.
Horizon Databook has segmented the Uae ai in oncology market based on hardware, software solutions, services covering the revenue growth of each sub-segment from 2021 to 2033.
Research institutes play a crucial role in driving the UAE AI in oncology market by contributing to advancements in AI technology and its application in the field of oncology. Through extensive R&D activities, these institutes work on refining AI algorithms, analyzing large datasets, and developing innovative solutions that can enhance cancer therapy.
Furthermore, hospitals are adopting AI technologies for cancer detection, diagnosis, treatment planning, and patient management. By incorporating AI algorithms, cancer hospitals can analyze medical images, genomic data, and other patient information more efficiently and accurately.
For instance, in August 2023, MBZUAI generated an AI model for accurate few-shot tissue image generation to recognize various cancer tissues. In May 2023, Cleveland Clinic Abu Dhabi introduced the Fatima bint Mubarak Center. The center uses Ethos adaptive radiotherapy, an AI-ML-based cancer treatment technology.
Uae Ai In Oncology Market Component Outlook (Revenue, USD Million , 2021-2033)
Hardware
Software Solutions
Services
Uae Ai In Oncology Market Cancer Type Outlook (Revenue, USD Million , 2021-2033)
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Brain Tumour
Others
Uae Ai In Oncology Market Application Outlook (Revenue, USD Million , 2021-2033)
Diagnostics (Pathology, Cancer Radiology)
Radiation therapy (Radiotherapy)
Research & Development (Drug design, development process, etc.)
Chemotherapy
Immunotherapy
Uae Ai In Oncology Market End Use Outlook (Revenue, USD Million , 2021-2033)
Hospitals
Surgical Centers & Medical Institutes
Others (Pharmaceutical companies, Research institutes & training centers)
Reasons to subscribe to AI In Oncology Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of AI In Oncology Market Outlook databook
Our clientele includes a mix of AI In Oncology Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE AI In Oncology Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into UAE AI In Oncology Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.